Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635441000168115 | Biaxsig (roxithromycin 300 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3635451000168118 | Biaxsig 300 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Biaxsig 300 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Biaxsig 300 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Biaxsig 300 mg tablet | Is a | Biaxsig | true | Inferred relationship | Some | ||
| Biaxsig 300 mg tablet | Is a | roxithromycin 300 mg tablet | true | Inferred relationship | Some | ||
| Biaxsig 300 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Biaxsig 300 mg tablet | has intended active ingredient | roxithromycin | true | Inferred relationship | Some | 583546478 | |
| Biaxsig 300 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 583546479 | |
| Biaxsig 300 mg tablet | has Australian BoSS | roxithromycin | true | Inferred relationship | Some | 583546478 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Biaxsig 300 mg tablet, 5 | has TPUU | True | Biaxsig 300 mg tablet | Inferred relationship | Some | 1 |
| Biaxsig 300 mg tablet, 5, blister pack | has TPUU | True | Biaxsig 300 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR